Crowdonomics
WatchlistPortfolio
All companies
Aether THERAPEUTICS logo

Aether THERAPEUTICS

Operating

Healthcare · Founded 2017

Visit website

Addressing the opioid crisis

Post-money valuation ⓘ
$17.7M
As of Dec 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$4,287,678
Crowd $210K · Private $4.1M · 2 rounds since 2024
Latest share price
$3.68
Reg CF · Common Stock · Aug 2024 offering price

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$0
−$20K
2022
$0
$147K
2023
$0
−$1.1M
2024
$0
−$580K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
FY2024 reviewed
FY2025
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
-$20,468
$147,198
-$1,070,791
-$580,436
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$16,530
$176,687
$9,067
$63,792
Accounts receivable
$0
$0
$0
$0
Total assets
$16,530
$182,422
$9,610
$75,756
Short-term debt
$0
$0
$0
$404,977
Long-term debt
$0
$0
$115,000
$0
Total liabilities
$0
$0
$115,000
$404,977
Other
Headcount
—
3
2
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$17.5M
pre-money
Reg CF · Common · Aug 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Aug 2024Closedvia Netcapital
Raised $209.7K / $800KPost-money $17.7M
Rule 506(b) · Equity · Jan 2024Closed
Raised $4.1MInvestors 1

Team

3 people
John Harris
Principal Executive Officer
Jon Saxe
Principal Accounting Officer
Wolfgang Sadee
Board Member

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 2 annual reports (FY2024–FY2025)

1 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-AROct 1, 20260002004745-26-000004
    EDGAR
  • Form C-ARJun 9, 20250001669191-25-000390
    EDGAR
  • Form C-UFeb 21, 20250001669191-25-000128
    EDGAR
  • Form C/ASep 6, 20240001669191-24-000910
    EDGAR
  • Form CAug 21, 20240001669191-24-000880
    EDGAR
  • Form DJan 19, 20240002004745-24-000001
    EDGAR
Source: ManualCIK 0002004745Share price $3.68

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.